Literature DB >> 32520512

PET/CT of COVID-19 as an Organizing Pneumonia.

Jaime Alonso Sanchez1, Julia García Prieto1, Alvaro Galiana Morón2, John Patrick Pilkington-Woll2.   

Abstract

An 85-year-old woman with history of melanoma is referred for a follow-up F-FDG PET/CT. F-FDG PET/CT scan showed bilateral and peripheral ground-glass opacities in upper and lower pulmonary lobes surrounded by consolidations of crescent shape with increased FDG uptake, findings compatible with organizing pneumonia. Following further inquiry, the patient reported low-grade fever, sore throat, and fatigue for the past 6 days. Because of the ongoing COVID-19 pandemic, the patient was tested for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which resulted positive.

Entities:  

Mesh:

Year:  2020        PMID: 32520512      PMCID: PMC7315838          DOI: 10.1097/RLU.0000000000003174

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   10.782


A, Chest CT scan. B, PET. We report the case of an 85-year-old woman with history of melanoma referred for FDG PET/CT. The PET/CT showed bilateral and peripheral ground-glass opacities with areas of focal consolidation primarily in left upper lobe (A, black arrow) and crescent-shaped consolidations in right and left lower lobes (A, white arrows). These findings are also known as reversed halo sign. 18F-FDG PET/CT showed increased FDG uptake (B). 18F-FDG PET/CT findings are compatible with an organizing pneumonia pattern suggestive of an infectious or inflammatory etiology. Following further inquiry, the patient reported history of low-grade fever, fatigue, and sore throat for the past 6 days. The patient was referred to the emergency department where, after careful review of the symptoms, she underwent a reverse transcriptase–polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which tested positive. She was admitted to the hospital and discharged 5 days later with complete resolution of the initial symptoms after treatment. COVID-19 is a disease caused by SARS-CoV-2, a new coronavirus that was first reported in China. Cough and fever are the most common symptoms, but the disease could be fatal in patients with multiple comorbidities.[1,2] The diagnosis of COVID-19 could be challenging because symptoms can overlap with other diseases such as influenza, adenovirus, Middle East respiratory syndrome, or SARS.[3] CT scan is a very sensitive tool in initial stages of the disease,[4] and findings often consist in unilateral or bilateral ground-glass opacities (often rounded morphology) with or without consolidation in early phases. As time passes, superimposed consolidations over previous ground-glass opacities are the most frequent pattern with septal thickening, bronchiectasis, pleural thickening, and effusion.[5-7] 18F-FDG PET/CT findings include avid lung parenchyma and mediastinal node FDG uptake, reflecting a significant inflammatory response.[8-11] Although 18F-FDG PET/CT is not routinely indicated for inflammatory disease, COVID-19 may be found incidentally,[10] and nuclear medicine professionals must be aware of the typical findings.[12-15]
  15 in total

1.  Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management.

Authors:  Yan Li; Liming Xia
Journal:  AJR Am J Roentgenol       Date:  2020-03-04       Impact factor: 3.959

2.  Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome.

Authors:  Melina Hosseiny; Soheil Kooraki; Ali Gholamrezanezhad; Sravanthi Reddy; Lee Myers
Journal:  AJR Am J Roentgenol       Date:  2020-02-28       Impact factor: 3.959

3.  Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region.

Authors:  Domenico Albano; Francesco Bertagna; Mattia Bertoli; Giovanni Bosio; Silvia Lucchini; Federica Motta; Maria Beatrice Panarotto; Alessia Peli; Luca Camoni; Frank M Bengel; Raffaele Giubbini
Journal:  J Nucl Med       Date:  2020-04-01       Impact factor: 10.057

4.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

5.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.

Authors:  Heshui Shi; Xiaoyu Han; Nanchuan Jiang; Yukun Cao; Osamah Alwalid; Jin Gu; Yanqing Fan; Chuansheng Zheng
Journal:  Lancet Infect Dis       Date:  2020-02-24       Impact factor: 25.071

6.  FDG PET/CT of COVID-19.

Authors:  Sijuan Zou; Xiaohua Zhu
Journal:  Radiology       Date:  2020-03-06       Impact factor: 11.105

7.  Incidental CT Findings Suspicious for COVID-19-Associated Pneumonia on Nuclear Medicine Examinations: Recognition and Management Plan.

Authors:  Mark Tulchinsky; Joseph S Fotos; Einat Slonimsky
Journal:  Clin Nucl Med       Date:  2020-07       Impact factor: 10.782

8.  The potential added value of FDG PET/CT for COVID-19 pneumonia.

Authors:  Yan Deng; Lei Lei; Yue Chen; Wei Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-21       Impact factor: 9.236

9.  Emerging Attack and Management Strategies for Nuclear Medicine in Responding to COVID-19-ACNM Member Experience and Advice.

Authors:  Yang Lu; Xiaohua Zhu; Sean Xuexian Yan; Xiaoli Lan
Journal:  Clin Nucl Med       Date:  2020-07       Impact factor: 10.782

10.  18F-FDG PET/CT and Serial Chest CT Findings in a COVID-19 Patient With Dynamic Clinical Characteristics in Different Period.

Authors:  Chunbao Liu; Jun Zhou; Liang Xia; Xiaojie Cheng; Diyu Lu
Journal:  Clin Nucl Med       Date:  2020-06       Impact factor: 10.782

View more
  3 in total

1.  [18F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function.

Authors:  Eva María Triviño-Ibáñez; Beatriz María Jiménez-Rodríguez; Teodoro Rudolphi-Solero; Encarnación Yolanda García-Rivero; Antonio Rodríguez-Fernández; José Manuel Llamas-Elvira; Manuel Gómez-Río; Concepción Morales-García
Journal:  Diagnostics (Basel)       Date:  2022-03-29

2.  Inflammatory response in lungs and extrapulmonary sites detected by [18F] fluorodeoxyglucose PET/CT in convalescing COVID-19 patients tested negative for coronavirus.

Authors:  Yan Bai; Junling Xu; Lijuan Chen; Chang Fu; Georges Ei Fakhri; Jianqin Gu; Fengmin Shao; Meiyun Wang; Yi Kang; Weifeng Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-09       Impact factor: 9.236

Review 3.  A comprehensive review of imaging findings in COVID-19 - status in early 2021.

Authors:  Ali Afshar-Oromieh; Helmut Prosch; Cornelia Schaefer-Prokop; Karl Peter Bohn; Ian Alberts; Clemens Mingels; Majda Thurnher; Paul Cumming; Kuangyu Shi; Alan Peters; Silvana Geleff; Xiaoli Lan; Feng Wang; Adrian Huber; Christoph Gräni; Johannes T Heverhagen; Axel Rominger; Matthias Fontanellaz; Heiko Schöder; Andreas Christe; Stavroula Mougiakakou; Lukas Ebner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-01       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.